Press Release|Articles|December 2, 2024

Camber Pharmaceuticals Introduces Lidocaine HCI Injection, USP, in Single- and Multi-Dose Vials

Listen

0:00 / 0:00

Key Takeaways

Camber Pharmaceuticals introduces Lidocaine HCl Injection in single-dose and multi-dose vials with 1% and 2% concentrations.
The product is available in various vial and pack sizes to meet diverse healthcare needs.
Camber, a subsidiary of Hetero, focuses on delivering high-quality generic medications for cost-effective healthcare solutions.
Expertise in APIs and finished dosage manufacturing ensures global access to affordable, reliable pharmaceuticals.

Featuring 1% and 2% concentrations, this versatile product is available in various vial and pack sizes to meet diverse healthcare needs.

Camber Pharmaceuticals is excited to introduce Lidocaine HCl Injection, USP, in Single-Dose and Multi-Dose Vials. Featuring 1% and 2% concentrations, this versatile product is available in various vial and pack sizes to meet diverse healthcare needs.

Click below to learn more:

Single-Dose Vials: https://www.camberpharma.com/products/lidocaine-sdv/
Multi-Dose Vials: https://www.camberpharma.com/products/lidocaine-mdv/

Camber Pharmaceuticals, a fully integrated pharmaceutical company, is dedicated to delivering high-quality generic medications that enhance lives through cost-effective healthcare solutions. As a subsidiary of Hetero, a global leader in active pharmaceutical ingredients (APIs) and finished dosage manufacturing based in Hyderabad, India, Camber leverages its expertise to ensure access to affordable, reliable pharmaceuticals for consumers worldwide.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME

Webinar Registration

Improving Outcomes in Lipid Management: Aligning Managed Care Policy With Emerging Guideline Updates and Non-Statin Therapeutic Advances

Tuesday, June 23, 2026 | 1:00 PM & 7:00 PM EDT

Camber Pharmaceuticals Introduces Lidocaine HCI Injection, USP, in Single- and Multi-Dose Vials

Key Takeaways

Related Content

Camber Launches Abacavir and Lamivudine Tablets, USP

Camber Launches Colchicine Capsules

Camber Pharmaceuticals Adds Metformin Hydrochloride Oral Solution to Growing Portfolio

Camber Launches Prucalopride Tablets

Camber Announces Addition of Chlorpromazine HCl Injection, USP

Latest CME

Improving Outcomes in Lipid Management: Aligning Managed Care Policy With Emerging Guideline Updates and Non-Statin Therapeutic Advances

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

Breast Cancer Day of Education 2026

Translating KDIGO Updates and Clinical Evidence Into Managed Care Decision-Making in IgA Nephropathy

Lymphoma Day of Education 2026

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

Managing Overactive Bladder in Older Adults: Challenges and Strategies for Long-Term Care

Managing Steroid-Refractory Chronic Graft-versus-Host Disease With Novel Therapies: Opportunities for Pharmacist-Led Interventions

Advancing the Idiopathic Pulmonary Fibrosis Treatment Landscape: What’s Next in Care

Exploring Immunotherapy Strategies in Endometrial Cancer

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

Collaborative Practice Agreement Implementation and Adherence: A Practical Roadmap for Oncology Pharmacists

The Educated Pharmacist: Overcoming Clinical Inertia—An Interactive Case Workshop for Optimizing Insulin Use

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations

Breast Cancer Day of Education 2026

Neuropsychiatry Day of Education 2026

New Therapeutic Targets in the Treatment of Generalized Myasthenia Gravis: Understanding Disease Pathways and Pharmacist-Led Strategies for Optimized Care

From Payload to Patient: Managing Toxicities of Antibody-Drug Conjugates Directed at HER2 and TROP2

Two Targets, One Mission: Optimizing Bispecific Antibody Use in Non-Hodgkin Lymphoma

Advancing Chronic Kidney Disease Detection and Cardiovascular Risk Reduction in Complex Patients

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations (Pharmacy Technician Credit)

From Evidence to Access: Integrating SGLT2 Inhibitors Across the Cardiorenal-Metabolic Continuum

Identifying and Personalizing Iron Deficiency Anemia Treatment in Patients With Cancer

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

Exploring Oncolytic Viruses in Melanoma: Pharmacist-Led Approaches for Safe Integration

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

From Guidelines to Action: Implementing Pneumococcal Vaccine ACIP Recommendations in Long-Term Care Settings

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Reducing the Treatment Burden in HIV Management: The Pharmacist’s Role in Long-Acting Injectable Adoption

Addressing Vaccine Hesitancy in Infectious Disease Prevention

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Addressing Gaps in Care for the Rapid and Long-Term Management of Hyperkalemia With Novel Oral Potassium Binding Agents: Insights for Managed Care Professionals

Beyond the Nasal Passage: Managing Chronic Rhinosinusitis With Nasal Polyps With Biologics and Pharmacist-Led Approaches

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

The Educated Pharmacist: Using Patient Insights to Personalize Insulin Therapy and Prevent Clinical Inertia

Adapting to Advances in EGFR-Positive Non-Small Cell Lung Cancer Treatment: Critical Insights for Oncology Pharmacists

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

Biomarker Testing in Practice: Navigating Modalities and Multidisciplinary Decision-Making

Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

The Pharmacist's Role in Palliative and End of Life Symptom Management

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Lymphomas: A Practical Guide for Pharmacists

Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease

Enhancing Patient Outcomes in Metastatic Colorectal Cancer: Equipping Community, Veterans Affairs, and Oncology Pharmacists to Navigate Care in the Third-Line Setting and Beyond